Resources Contact Us Home
Binding peptides for carcinoembryonic antigen (CEA)

Image Number 5 for United States Patent #7438890.

The present invention provides binding moieties for CEA, which have a variety of uses wherever detecting, isolating or localizing CEA, and particularly CEA as opposed to cross-reactive antigens such as NCA, is advantageous. Particularly disclosed are synthetic, isolated polypeptides capable of binding CEA, which is overexpressed in adenocarcinomas of endodermally derived digestive system epithelia and fetal colon. Such polypeptides and disclosed derivatives are useful, e.g., as imaging agents for CEA-expressing tumors.

  Recently Added Patents
Pharmaceutical and diagnostic compositions for use in the treatment and diagnosis of neurodegenerative diseases or amyloid diseases
Information processing apparatus, information processing method, and program
Austenitic stainless steel welding wire and welding structure
Method and system for remapping processing elements in a pipeline of a graphics processing unit
Leg mounted portable computer
User-initiated quality of service modification in a mobile device
Intraoral camera for dental chairs
  Randomly Featured Patents
Surfactant additives for solid propellants
Method of determining dispersion, particle density or viscosity of resin/solvent mixture containing magnetic particles
Bioassay for toxic substances activated by metabolic enzyme system
Storing data on fiber data storage media
Vehicle wheel front face
Monitoring and tracking of wireless sensor devices
Method and system for differential diagnosis based on clinical and radiological information using artificial neural networks
Liquid crystal display device
Automatic chemical analyzer
Mono(cyclobutarene)/polymaleimide copolymers